digital privacy statement.
Six months after PGCA may be too soon to identify prostate cancer persistence with PSA and MRI.
PSA reliably detects risk, even in men with end-stage kidney disease and liver failure, study finds.
Inadequate therapy raises risk of recurrence and poor outcomes.
Urology Highlights 2019–2020
Doctors treat patient using next-generation sequencing, targeted adjuvant therapy, and a neobladder.
Explore the Issue
We can help you find a doctor.
browse our specialists.